Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 396,460 |
|
|||||
| News | - | ||||||
| Day High | 42.93 | Low High |
|||||
| Day Low | 40.22 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apogee Therapeutics Inc | APGE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.98 | -4.59% | 41.14 | 18:13:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 42.23 | 40.22 | 42.93 | 41.14 | 43.12 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,674 | 396,460 | US$ 41.41 | US$ 16,415,519 | - | 14.19 - 72.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:05:04 | priorref | 6,500 | US$ 41.14 | USD |
Apogee Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.08B | 50.66M | - | 0 | -83.99M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apogee Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APGE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.70 | 45.97 | 40.22 | 43.08 | 342,623 | -0.56 | -1.34% |
| 1 Month | 54.59 | 54.59 | 40.22 | 46.03 | 372,943 | -13.45 | -24.64% |
| 3 Months | 67.63 | 71.75 | 40.22 | 53.55 | 442,124 | -26.49 | -39.17% |
| 6 Months | 22.78 | 72.29 | 20.78 | 51.21 | 529,127 | 18.36 | 80.60% |
| 1 Year | 21.50 | 72.29 | 14.19 | 40.40 | 437,377 | 19.64 | 91.35% |
| 3 Years | 21.50 | 72.29 | 14.19 | 40.40 | 437,377 | 19.64 | 91.35% |
| 5 Years | 21.50 | 72.29 | 14.19 | 40.40 | 437,377 | 19.64 | 91.35% |
Apogee Therapeutics Description
| Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. |
